Management of Bipolar I Disorder with Comorbid Anxiety, Depression, and PTSD

Medication Optimization

The American College of Psychiatrists recommends optimizing cariprazine to 1.5-3mg daily for bipolar depression, while adding an SSRI (sertraline or escitalopram) combined with cognitive behavioral therapy (CBT) to address extreme anxiety, ruminations, and compulsive behaviors, with careful monitoring for mood destabilization 1
Continue bupropion 150mg as it provides antidepressant effects with lower risk of mood destabilization compared to SSRIs when used alone, but always combine with a mood stabilizer (cariprazine in this case) to prevent mania induction 1
Prazosin should be continued for PTSD-related nightmares and hyperarousal, as it is evidence-based for these specific symptoms 2

Cognitive Behavioral Therapy (CBT) is mandatory for this patient, with combination treatment (medication + CBT) being superior to either alone for anxiety, depression, and PTSD, and should be implemented immediately 1
Graded self-exposure based on CBT principles should be considered for PTSD symptoms 2

Benzodiazepines should NOT be used as first-line treatment for chronic anxiety in this patient despite the severity of symptoms, due to risks of tolerance, dependence, and overdose 1, 2
If acute anxiety management is needed during SSRI titration, use low-dose lorazepam 0.25-0.5mg PRN (maximum 2mg daily, not more than 2-3 times weekly) with clear time-limited parameters 1

Weekly visits for the first month are recommended to assess for mood destabilization, SSRI tolerability, and treatment response, followed by monthly visits once stable 1
Continue combination therapy for at least 12-24 months after achieving stability, as premature discontinuation leads to relapse rates exceeding 90% 1